Evidence map›Paper›PMID 23608535›Full record

ArticleMolecular and cellular biology2013

Mitogen-activated protein kinase-activated protein kinases 2 and 3 regulate SERCA2a expression and fiber type composition to modulate skeletal muscle and cardiomyocyte function.

Madeleine Scharf, Stefan Neef, Robert Freund, Cornelia Geers-Knörr, Mirita Franz-Wachtel, Almuth Brandis, Dorothee Krone, Heike Schneider, Stephanie Groos, Manoj B Menon and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 57 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. PeerJ · 2021
    Article
  14. The p38Frontiers in cell and developmental biology · 2021
    Review
  15. p38 MAPK Pathway in the Heart: New Insights in Health and Disease.International journal of molecular sciences · 2020
    Review
  16. Article
  17. Suppression of CaEMBO reports · 2020
    Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 4 countries.

Madeleine ScharfDepartment of Biochemistry, Hannover Medical School, Hannover, Germany.
Stefan Neef
Robert Freund
Cornelia Geers-Knörr
Mirita Franz-Wachtel
Almuth Brandis
Dorothee Krone
Heike Schneider
Stephanie Groos
Manoj B Menon
Kin-Chow Chang
Theresia Kraft
Joachim D Meissner
Kenneth R Boheler
Lars S Maier
Matthias Gaestel
Renate J Scheibe
Medizinische Hochschule Hannover · DEUniversity of Göttingen · DENational Institutes of Health · USUniversity of Nottingham · GBUniversity of Tübingen · DE

Funding

Biotechnology and Biological Sciences Research Council BB/F018487/1
6 · The paper itself

Abstract

The mitogen-activated protein kinase (MAPK)-activated protein kinases 2 and 3 (MK2/3) represent protein kinases downstream of the p38 MAPK. Using MK2/3 double-knockout (MK2/3(-/-)) mice, we analyzed the role of MK2/3 in cross-striated muscle by transcriptome and proteome analyses and by histology. We demonstrated enhanced expression of the slow oxidative skeletal muscle myofiber gene program, including the peroxisome proliferator-activated receptor gamma (PPARγ) coactivator 1α (PGC-1α). Using reporter gene and electrophoretic gel mobility shift assays, we demonstrated that MK2 catalytic activity directly regulated the promoters of the fast fiber-specific myosin heavy-chain IId/x and the slow fiber-specific sarco/endoplasmic reticulum Ca(2+)-ATPase 2 (SERCA2) gene. Elevated SERCA2a gene expression caused by a decreased ratio of transcription factor Egr-1 to Sp1 was associated with accelerated relaxation and enhanced contractility in MK2/3(-/-) cardiomyocytes, concomitant with improved force parameters in MK2/3(-/-) soleus muscle. These results link MK2/3 to the regulation of calcium dynamics and identify enzymatic activity of MK2/3 as a critical factor for modulating cross-striated muscle function by generating a unique muscle phenotype exhibiting both reduced fatigability and enhanced force in MK2/3(-/-) mice. Hence, the p38-MK2/3 axis may represent a novel target for the design of therapeutic strategies for diseases related to fiber type changes or impaired SERCA2 function.

Indexed as

AnimalsEarly Growth Response Protein 1Gene Expression RegulationIntracellular Signaling Peptides and ProteinsMAP-Kinase-Activated Kinase 2MiceMice, KnockoutMice, TransgenicMitogen-Activated Protein Kinase 12Mitogen-Activated Protein Kinase 14Muscle ContractionMuscle Fibers, SkeletalMuscle, SkeletalMyocytes, CardiacPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPromoter Regions, GeneticEarly Growth Response Protein 1Egr1 protein, mouseIntracellular Signaling Peptides and ProteinsMAP-Kinase-Activated Kinase 2MAP-kinase-activated kinase 3Mitogen-Activated Protein Kinase 12Mitogen-Activated Protein Kinase 14Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPpargc1a protein, mouseProtein Serine-Threonine KinasesSarcoplasmic Reticulum Calcium-Transporting ATPasesTrans-ActivatorsTranscription Factors

Identifiers

PMID23608535
PMCPMC3700115
OpenAlexW2164651336

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.